Drugs giant GSK picks Symonds to steer £81bn break-up

Posted on by

Britain’s second-biggest drug-maker is turning to a former chief financial officer of AstraZeneca, its London-listed rival, to steer it through an £81bn break-up.
Source: Sky Business News